ISRCTN24498451
Active, not recruiting
未知
A comparison of pharmacogenomic raw genotyping data from direct-to-consumer genetic testing services and third-party interpretation websites with conventional laboratory testing
niversity Hospital of Zurich0 sites20 target enrollmentStarted: August 10, 2023Last updated:
Overview
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- niversity Hospital of Zurich
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1\. Signed informed consent
- •2\. Ability to understand and follow study procedures and understand informed consent
- •3\. Age 18\-75 years
Exclusion Criteria
- •1\. People at higher risk for infection: age over 75 years, people taking immunosuppressive drugs or with immunodeficiencies
- •2\. People at higher risk for blood loss: people taking anticoagulation and or antiplatelet drugs, people with coagulation disorders
Investigators
Similar Trials
Completed
Not Applicable
Genotype-guided warfarin dosing studyKCT0004586Ewha Womans University91
Completed
Not Applicable
Genotyping and Therapeutic Drug Monitoring in Epileptic patients on Phenytoin : RCTHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromesCTRI/2019/09/021317Dr Nithya Gogtay50
Completed
Not Applicable
Genotyping and TDM in Epileptic patients on CBZ : RCTHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromesCTRI/2019/09/021311Dr Nithya Gogtay50
Not yet recruiting
Not Applicable
Effect of genetic profile on hemodynamic changes following etomidate induction.Health Condition 1: O- Medical and SurgicalCTRI/2024/05/067100Maulana Azad medical college and associated Lok Nayak hospital
Not yet recruiting
Not Applicable
Treatment with Tapentadol in Cancer PatientsHealth Condition 1: G893- Neoplasm related pain (acute) (chronic)CTRI/2020/11/029206Manipal Academy of Higher Education